Millennium Management’s Veracyte VCYT Stock Holding History

Millennium Management’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.71M	Buy	+146,300	New	+$5.42M	﹤0.01%	3014
2025 Q1	–	Sell	-100,000	Closed	-$3.96M	–	6430
2024 Q4	$3.96M	Sell	100,000 -300	-0.3%	-$11.4K	﹤0.01%	3030
2024 Q3	$3.41M	Buy	+100,300	New	+$2.82M	﹤0.01%	3187
2024 Q1	–	Sell	-50,000	Closed	-$1.38M	–	6689
2023 Q4	$1.38M	Sell	50,000 -50,000	-50%	-$1.21M	﹤0.01%	3906
2023 Q3	$2.23M	Buy	+100,000	New	+$2.57M	﹤0.01%	3453
2021 Q2	–	Sell	-100,000	Closed	-$5.38M	–	7142
2021 Q1	$5.38M	Buy	100,000 +48,000	+92%	+$2.76M	﹤0.01%	2491
2020 Q4	$2.54M	Buy	+52,000	New	+$2.41M	﹤0.01%	3040

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Millennium Management's VCYT Position: Q1 2026 in Review

Millennium Management sold out of Veracyte (VCYT) in Q1 2026, closing a stake of 89,879 shares — an estimated $3.33M sold.

Millennium Management first reported a position in VCYT in Q4 2013 and held it in 45 quarters. The position peaked at $20.5M in Q1 2019. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

Millennium Management reported no remaining Veracyte position as of Q1 2026 after selling out during the quarter.
Millennium Management sold 89,879 Veracyte shares in Q1 2026, an estimated $3.33M.
Millennium Management first reported a position in Veracyte in Q4 2013 and held it in 45 quarters.
Millennium Management's Veracyte position peaked at $20.5M in Q1 2019.
334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.